Jakarta - Delayed Quote IDR

PT Metro Healthcare Indonesia Tbk (CARE.JK)

144.00 +5.00 (+3.60%)
At close: April 26 at 4:00 PM GMT+7
Key Events
Loading Chart for CARE.JK
DELL
  • Previous Close 139.00
  • Open 136.00
  • Bid 145.00 x --
  • Ask 134.00 x --
  • Day's Range 136.00 - 144.00
  • 52 Week Range 110.00 - 545.00
  • Volume 823,200
  • Avg. Volume 72,052,115
  • Market Cap (intraday) 4.788T
  • Beta (5Y Monthly) -0.46
  • PE Ratio (TTM) --
  • EPS (TTM) -3.34
  • Earnings Date May 3, 2024 - May 7, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

PT Metro Healthcare Indonesia Tbk owns, operates, and manages hospitals in Indonesia. It is involved in the management of clinics, treatment halls, polyclinics, and other medical centers; healthcare, physical medicine, and trading businesses; operates private polyclinics; and provides industry, development, and services, as well as health and management consulting services. The company was founded in 2015 and is based in Tangerang, Indonesia. PT Metro Healthcare Indonesia Tbk is a subsidiary of PT Metro Healthcare International.

www.metrohealthcareindonesia.co.id

742

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: CARE.JK

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CARE.JK
10.00%
IDX COMPOSITE
3.25%

1-Year Return

CARE.JK
70.85%
IDX COMPOSITE
3.14%

3-Year Return

CARE.JK
55.56%
IDX COMPOSITE
16.94%

5-Year Return

CARE.JK
--
IDX COMPOSITE
43.37%

Compare To: CARE.JK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CARE.JK

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    4.79T

  • Enterprise Value

    4.99T

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    19.73

  • Price/Book (mrq)

    1.55

  • Enterprise Value/Revenue

    20.55

  • Enterprise Value/EBITDA

    -164.35

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -45.71%

  • Return on Assets (ttm)

    -0.54%

  • Return on Equity (ttm)

    -3.51%

  • Revenue (ttm)

    242.68B

  • Net Income Avi to Common (ttm)

    -110.92B

  • Diluted EPS (ttm)

    -3.34

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    754.76B

  • Total Debt/Equity (mrq)

    30.81%

  • Levered Free Cash Flow (ttm)

    -57.14B

Company Insights: CARE.JK

People Also Watch